Equity Analysis /
United States of America

US : Denali Therapeutics Inc. - DNLI | Assuming Coverage: Novel Neuro Platform Holds Promise But Still Early & High Risk

    Danielle Brill
    CGS-CIMB
    9 December 2021
    Published by